Retroviral delivery of transforming growth factor-β1 to myeloid dendritic cells: Inhibition of T-cell priming ability and influence on allograft survival

Transplantation

Volumn 74, Issue 1, 2002, Pages 112-119

  Takayama, Takuya ^a   Kaneko, Katsuhiko ^a   Morelli, Adrian E ^a   Li, Wei ^a   Tahara, Hideaki ^a   Thomson, Angus W ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CHROMIUM 51; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; RETROVIRUS VECTOR; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA1;

ALLOSTERISM; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL LINEAGE; CELL MIGRATION; CELL STIMULATION; CENTRIFUGE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG ACTIVITY; ENZYME IMMUNOASSAY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0037099209     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200207150-00019     Document Type: Article

References (38)

1. Dendritic cells and the control of immunity
2. Migration of dendritic leukocytes from cardiac allografts into host spleens: A novel pathway for initiation of rejection
3. Immunobiology of dendritic cells
4. Identification of proliferating dendritic cell precursors in mouse blood
5. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells
6. Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow
7. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
8. The nature of allorecognition
9. Immunogenicity of retransplanted rat kidney allografts: Effect of inducing chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient
10. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes
11. -) prolong cardiac allograft survival in nonimmunosuppressed recipients
12. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo
13. Peritransplant tolerance induction in macaques: Early events reflecting the unique synergy between immunotoxin and deoxyspergualin
14. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
15. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
16. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness
17. Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients
18. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival
19. Transforming growth factor-B and its receptors
20. Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice
21. + T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta
22. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation
23. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival
24. Transduction of dendritic cell progenitors with a retroviral vector encoding viral interleukin-10 and enhanced green fluorescent protein allows purification of potentially tolerogenic antigen-presenting cells
25. Gene therapy in transplantation
26. Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro
27. Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta
28. Induction of antigen-specific immunosuppression by CD95L cDNA-transfected "killer" dendritic cells
29. Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway
30. TGF-beta 1 reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors
31. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: Modulation by tacrolimus
32. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts
33. Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4
34. Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis
35. Synergy in induction of increased renal allograft survival after portal vein infusion of dendritic cells transduced to express TGFbeta and IL-10, along with administration of CHO cells expressing the regulatory molecule OX-2
36. A dendritic cell line genetically modified to express CTLA4-Ig as a means to prolong islet allograft survival
37. The evolution of self-tolerance: A new cell arises to meet the challenge of self-reactivity
38. Immature and mature CD8alpha+ dendritic cells prolong the survival of vascularized heart allografts